266 related articles for article (PubMed ID: 30496141)
1. Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer.
Ding Y; Li N; Dong B; Guo W; Wei H; Chen Q; Yuan H; Han Y; Chang H; Kan S; Wang X; Pan Q; Wu P; Peng C; Qiu T; Li Q; Gao D; Xue W; Qin J
J Clin Invest; 2019 Feb; 129(2):759-773. PubMed ID: 30496141
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells.
Watanabe T; Semba S; Yokozaki H
Br J Cancer; 2011 Jan; 104(1):146-54. PubMed ID: 21102582
[TBL] [Abstract][Full Text] [Related]
4. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
5. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.
Naidu SR; Love IM; Imbalzano AN; Grossman SR; Androphy EJ
Oncogene; 2009 Jul; 28(27):2492-501. PubMed ID: 19448667
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.
Lv DJ; Song XL; Huang B; Yu YZ; Shu FP; Wang C; Chen H; Zhang HB; Zhao SC
Theranostics; 2019; 9(18):5166-5182. PubMed ID: 31410208
[No Abstract] [Full Text] [Related]
7. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract][Full Text] [Related]
9. An essential role for a mammalian SWI/SNF chromatin-remodeling complex during male meiosis.
Kim Y; Fedoriw AM; Magnuson T
Development; 2012 Mar; 139(6):1133-40. PubMed ID: 22318225
[TBL] [Abstract][Full Text] [Related]
10. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
[TBL] [Abstract][Full Text] [Related]
11. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
[TBL] [Abstract][Full Text] [Related]
12. Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells.
Wu Q; Sharma S; Cui H; LeBlanc SE; Zhang H; Muthuswami R; Nickerson JA; Imbalzano AN
Oncotarget; 2016 May; 7(19):27158-75. PubMed ID: 27029062
[TBL] [Abstract][Full Text] [Related]
13. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
[TBL] [Abstract][Full Text] [Related]
14. Evf2 lncRNA/BRG1/DLX1 interactions reveal RNA-dependent inhibition of chromatin remodeling.
Cajigas I; Leib DE; Cochrane J; Luo H; Swyter KR; Chen S; Clark BS; Thompson J; Yates JR; Kingston RE; Kohtz JD
Development; 2015 Aug; 142(15):2641-52. PubMed ID: 26138476
[TBL] [Abstract][Full Text] [Related]
15. The chromatin remodeling protein BRG1 links ELOVL3 trans-activation to prostate cancer metastasis.
Yang Y; Liu L; Li M; Cheng X; Fang M; Zeng Q; Xu Y
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):834-845. PubMed ID: 31154107
[TBL] [Abstract][Full Text] [Related]
16. OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.
Fu X; Zhao J; Yu G; Zhang X; Sun J; Li L; Yin J; Niu Y; Ren S; Zhu Y; Xu B; Huang L
Commun Biol; 2022 Mar; 5(1):182. PubMed ID: 35233061
[TBL] [Abstract][Full Text] [Related]
17. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways.
Alessio N; Squillaro T; Cipollaro M; Bagella L; Giordano A; Galderisi U
Oncogene; 2010 Oct; 29(40):5452-63. PubMed ID: 20697355
[TBL] [Abstract][Full Text] [Related]
18. The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer.
Wu Q; Lian JB; Stein JL; Stein GS; Nickerson JA; Imbalzano AN
Epigenomics; 2017 Jun; 9(6):919-931. PubMed ID: 28521512
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
Papillon JPN; Nakajima K; Adair CD; Hempel J; Jouk AO; Karki RG; Mathieu S; Möbitz H; Ntaganda R; Smith T; Visser M; Hill SE; Hurtado FK; Chenail G; Bhang HC; Bric A; Xiang K; Bushold G; Gilbert T; Vattay A; Dooley J; Costa EA; Park I; Li A; Farley D; Lounkine E; Yue QK; Xie X; Zhu X; Kulathila R; King D; Hu T; Vulic K; Cantwell J; Luu C; Jagani Z
J Med Chem; 2018 Nov; 61(22):10155-10172. PubMed ID: 30339381
[TBL] [Abstract][Full Text] [Related]
20. Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
Zhao D; Lu X; Wang G; Lan Z; Liao W; Li J; Liang X; Chen JR; Shah S; Shang X; Tang M; Deng P; Dey P; Chakravarti D; Chen P; Spring DJ; Navone NM; Troncoso P; Zhang J; Wang YA; DePinho RA
Nature; 2017 Feb; 542(7642):484-488. PubMed ID: 28166537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
